Best Oncology Knowledge Into Practice Podcasts (2025)

1
A Molecular Autopsy in Real Time 🧬⏱️Checkpoint Inhibitors, Multiorgan Damage ♟️🧬⚠️ 3:27

Play Pause

1h ago3:27

3:27

🧬 When immunity saves—and harms—at the same time A striking NEJM correspondence reveals that patients receiving immune checkpoint inhibitors often sustain molecularly detectable multiorgan damage—weeks to months before symptoms appear. Using cell-free DNA methylation mapping, investigators show that immune-related adverse events are systemic, not i…

1
Same Drink, Worse Morning 🍷⏳😖Alcohol vs the Aging Clock ⏰🍸😴 3:26

22h ago3:26

3:26

🍷⏳ Why Hangovers Get Worse as We Age — Science, Not Sentiment Ever wondered why the same drink that once sparkled now punishes? A Well Informed piece from The Economist explains how aging physiology—less body water, slower metabolism, disrupted sleep, and toxic metabolites—turns modest indulgence into a morning reckoning. 🧠💤☠️ The takeaway is not a…

1
⏳➡️⏰ Can Science Make Old Immune Cells Young Again? 5:25

2d ago5:25

5:25

🧬✨ Can we make the ageing immune system young again? A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, I…

1
Protein Moderation: Age Slower, Live Better 🧬⏳❤️ 5:10

3d ago5:10

5:10

🧬 Protein Restriction, Aging, and Longevity ⏳ A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️ Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefi…

1
Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease 39:59

3d ago39:59

39:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAH/CME information, and to apply for credit, please visit us at PeerView.com/BNE865. EBAH/CME c…

1
Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease 39:59

4d ago39:59

39:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAH/CME information, and to apply for credit, please visit us at PeerView.com/BNE865. EBAH/CME c…

1
Waves, Not Lone Rangers 🌊⚔️🧬: How Neutrophils Work Collectively 3:59

4d ago3:59

3:59

🧬 Rethinking Neutrophils: From Lone Cells to Living Systems 🧠⚔️ For over a century, neutrophils were seen as short-lived foot soldiers of immunity. This new Cell review reframes them as something far more interesting: a coordinated, adaptive collective. ✨ Key ideas: • Short-lived cells, long-term memory • Two compartments: granulopoietic + mature •…

1
🌙 Timing Is Tissue: Circadian Control of Neutrophils Limits Cardiac Damage 4:36

5d ago4:36

4:36

⏰🫀 Does the heart care about the time of day? Yes—profoundly. A new study in the Journal of Experimental Medicine reveals a circadian checkpoint in neutrophils that determines how much damage occurs after myocardial infarction. Morning ischemia triggers more injury, while nighttime CXCL12–CXCR4 signaling reprograms neutrophils, relocating them into…

1
Dr RR Baliga's Philosophical Discourses: Georg Wilhelm Friedrich Hegel (Germany, 1770–1831 CE) – German Idealism 5:24

6d ago5:24

5:24

Exploring Hegel's Vision of Progress and Freedom 🌍🔄✨ Reflecting on Georg Wilhelm Friedrich Hegel's remarkable insight that history is a dynamic journey toward greater human freedom. His dialectical lens — the idea that contradictions are not dead ends but engines of development — offers a powerful way to think about institutions, leadership, and ch…

1
Patient-Centered Head and Neck Cancer Survivorship 28:53

4h ago28:53

28:53

Dr. Chino talks with Dr. Talya Salz, the first author of the JCO OP manuscript "Impact of an Electronic Patient-Reported Outcome–Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD)" which was published earlier this year simultaneous to…

1
Curing Cancer, Guarding the Heart 🛡️ | Cardio-Oncology Playbook-1 5:40

7d ago5:40

5:40

🫀🧬 Cardio-Oncology: where modern cancer cures meet the heart As cancer survival improves, cardiovascular toxicity has emerged as a defining challenge of our time. From BTK inhibitor–associated atrial fibrillation ⚡, to immune checkpoint inhibitor myocarditis 🔥, to VEGF-driven hypertension 🩸, the heart increasingly pays the price of precision oncolo…

1
🧬 Prediabetes: Normalize Glucose, Save Hearts, Gain Decades ❤️📉⏳❤️ 4:35

8d ago4:35

4:35

🧬 Prediabetes remission is not just metabolic—it's cardiovascular medicine. ❤️ A new analysis in The Lancet Diabetes & Endocrinology shows that achieving remission to normoglycaemia—not merely delaying diabetes—was associated with a ~50% reduction in cardiovascular death or heart failure hospitalisation, with benefits persisting for 20–30 years acr…

1
Fat, Fire, and Fibrosis 🔥🧬🛑 Unmasking the Metabolic Engine Driving MASLD 4:54

9d ago4:54

4:54

🔬 New Insights on MASLD from JAMA 🍃 I recently reviewed an excellent JAMA article on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)—now recognized as the most common chronic liver disease worldwide. The review highlights how metabolic dysfunction, inflammation, and fibrosis converge to drive long-term risks, including cardiovascul…

1
Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer 40:01

10d ago40:01

40:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BWD86…

1
Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer 40:01

10d ago40:01

40:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BWD86…

1
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease 1:08:20

10d ago1:08:20

1:08:20

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT8…

1
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease 1:08:20

10d ago1:08:20

1:08:20

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT8…

1
The Brain's Hidden Rivers, Healing Flows, Hope Ahead 10:07

7h ago10:07

10:07

In this week's exploration, I dive into the brain's hidden "plumbing"—the glymphatic and meningeal lymphatic systems—drawing from a remarkable report in Science magazine (Dec 2025). The piece outlines emerging Alzheimer's strategies ranging from VEGF-C and Aquaporin-4 gene therapy to vasomotion drugs, CO₂ breathing, massage-based lymphatic stimulat…

1
Obesity, Innovation, Action: The WHO Roadmap for GLP-1 Therapies 🌐🚀📘 5:51

11d ago5:51

5:51

🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘 The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong…

1
🔥 Activated Immunity, Aggravated Coronary Plaques, Accelerated ACS 6:04

12d ago6:04

6:04

Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️. As immunotherapy transforms cancer care, we're learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺. This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and chall…

1
Dr RR Baliga's Philosophical Discourses: Immanuel Kant (Germany, 1724–1804 CE) – Critique of Pure Reason 7:19

13d ago7:19

7:19

Immanuel Kant: The Architect of Modern Reason 🧠✨ Fascinating to revisit Kant's legacy — the thinker who reshaped how we understand knowledge, morality, and human freedom. His ideas on autonomy, duty, and the categorical imperative continue to guide ethical reasoning in science, leadership, and society. From Critique of Pure Reason to Perpetual Peac…

1
📊 Detect, Diagnose, Defend: Protecting the Heart During ICI Therapy per IC-OS 🫀🧭🛡️ 5:29

14d ago5:29

5:29

🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡 Key insights include: • Early recognition wit…

1
From GFR to Global Health: CKD's Rising Tide 🌊📉🌐 6:03

15d ago6:03

6:03

Chronic kidney disease now affects nearly 850 million people worldwide, yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. 🌍🩺 The latest Lancet Seminar highlights powerful tools—eGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 th…

1
📅🔍🧠: A Natural Experiment Reveals Dementia-Slowing Effects of Vaccination 3:37

16d ago3:37

3:37

🚀 New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesn't just prevent viral reactivation—it may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up. 🔍 Using a strict …

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs 36:50

17d ago36:50

36:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WMS865. EBAC/CME c…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs 36:50

17d ago36:50

36:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WMS865. EBAC/CME c…

1
Covid, RSV, Influenza: The 2025–26 NEJM Update 🧬🔥📊 4:56

17d ago4:56

4:56

📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. 💉🛡️ Key insights: improved VE for updated Covid-19 strains…

1
Winning Against HFrEF 🥇💓🛠 Diagnose Early. Treat with GDMT. Follow Through 5:46

18d ago5:46

5:46

New Lancet Seminar on heart failure with reduced ejection fraction. 💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It's a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tu…

1
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence ... 22:27

19d ago22:27

22:27

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care 35:00

19d ago35:00

35:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NJR865. CME credit will…

1
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases 1:10:49

19d ago1:10:49

1:10:49

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration 38:01

19d ago38:01

38:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAD865. CME/MO…

1
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC 26:40

19d ago26:40

26:40

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration 38:01

19d ago38:01

38:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAD865. CME/MO…

1
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care 35:00

14d ago35:00

35:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NJR865. CME credit will…

1
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases 1:10:57

19d ago1:10:57

1:10:57

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView…

1
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC 26:40

19d ago26:40

26:40

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence ... 22:27

19d ago22:27

22:27

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Seeing CAD Clearly 🔍❤️: Plaque, Perfusion, Prognosis 📸💓📈 6:20

19d ago6:20

6:20

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it. From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ische…

1
Dr RR Baliga's Philosophical Discourses: David Hume (Scotland, 1711–1776 CE) – Skepticism and Empiricism 3:25

20d ago3:25

3:25

Exploring David Hume 🧠✨ Just revisited David Hume's extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, econo…

1
Heart Failure Rising 📈 | Risks Rewired 🔄 | America's 35-Year Shift 🇺🇸 4:42

21d ago4:42

4:42

The U.S. heart failure landscape is transforming—and fast. 🫀📊 A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️ These trends demand a new generation…